| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L23 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.41e-20 | 114 | 65 | 15 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L23 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.26e-20 | 124 | 65 | 15 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L23 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.48e-19 | 137 | 65 | 15 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L23 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.35e-17 | 192 | 65 | 15 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 USP17L23 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 MST1L USP17L22 USP17L15 USP17L13 USP17L18 | 2.13e-10 | 654 | 65 | 16 | GO:0008233 |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 1.82e-06 | 8 | 65 | 3 | GO:0140948 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 3.89e-06 | 10 | 65 | 3 | GO:0140947 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 9.20e-06 | 13 | 65 | 3 | GO:0046974 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.96e-04 | 44 | 65 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | ribonuclease P activity | 6.74e-04 | 12 | 65 | 2 | GO:0004526 | |
| GeneOntologyMolecularFunction | tRNA-specific ribonuclease activity | 1.37e-03 | 17 | 65 | 2 | GO:0004549 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.42e-03 | 68 | 65 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.48e-03 | 69 | 65 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.61e-03 | 71 | 65 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 3.22e-03 | 26 | 65 | 2 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 3.22e-03 | 26 | 65 | 2 | GO:0019707 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 4.00e-03 | 29 | 65 | 2 | GO:0005540 | |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 4.28e-03 | 30 | 65 | 2 | GO:0016417 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 4.62e-03 | 103 | 65 | 3 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 4.87e-03 | 105 | 65 | 3 | GO:0008170 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.24e-18 | 125 | 63 | 14 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 9.57e-18 | 144 | 63 | 14 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 KLHL25 USP17L12 USP17L17 USP17L20 TRIM26 USP17L11 USP17L24 USP17L6P USP17L5 RNF213 USP17L10 TNKS USP17L19 USP17L22 ZNF598 USP17L15 USP17L13 USP17L18 | 8.43e-11 | 1009 | 63 | 19 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 KLHL25 USP17L12 USP17L17 USP17L20 TRIM26 USP17L11 USP17L24 USP17L6P USP17L5 RNF213 USP17L10 TNKS USP17L19 USP17L22 ZNF598 USP17L15 USP17L13 USP17L18 | 2.43e-10 | 1074 | 63 | 19 | GO:0043687 |
| GeneOntologyBiologicalProcess | endolysosomal toll-like receptor signaling pathway | 2.58e-05 | 56 | 63 | 4 | GO:0140894 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 USP17L12 RDH16 SMIM14 USP17L17 USP17L20 USP17L11 TLR3 USP17L6P USP17L5 USP17L10 TLR7 USP17L19 USP17L22 USP17L15 TMCC3 USP17L13 USP17L18 | 2.81e-08 | 1293 | 63 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 USP17L12 RDH16 SMIM14 USP17L17 USP17L20 USP17L11 TLR3 USP17L6P USP17L5 USP17L10 TLR7 USP17L19 USP17L22 USP17L15 TMCC3 USP17L13 USP17L18 | 3.02e-08 | 1299 | 63 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 USP17L12 RDH16 SMIM14 USP17L17 USP17L20 USP17L11 TLR3 USP17L6P USP17L5 USP17L10 TLR7 USP17L19 USP17L22 USP17L15 TMCC3 USP17L13 USP17L18 | 4.18e-08 | 1327 | 63 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | ribonuclease P complex | 7.95e-04 | 14 | 63 | 2 | GO:0030677 | |
| GeneOntologyCellularComponent | endolysosome membrane | 1.64e-03 | 20 | 63 | 2 | GO:0036020 | |
| HumanPheno | Optic neuritis | 1.72e-05 | 23 | 12 | 3 | HP:0100653 | |
| HumanPheno | Neuroinflammation | 1.72e-05 | 23 | 12 | 3 | HP:0033429 | |
| HumanPheno | Glomerulonephritis | 9.24e-05 | 111 | 12 | 4 | HP:0000099 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 7.49e-25 | 16 | 61 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 7.49e-25 | 16 | 61 | 11 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 2.01e-18 | 66 | 61 | 12 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 4.30e-18 | 70 | 61 | 12 | PS00972 |
| Domain | UCH | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 5.16e-18 | 71 | 61 | 12 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 5.16e-18 | 71 | 61 | 12 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 6.17e-18 | 72 | 61 | 12 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 6.17e-18 | 72 | 61 | 12 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 6.17e-18 | 72 | 61 | 12 | IPR001394 |
| Domain | Evi1/Prdm16 | 1.05e-05 | 2 | 61 | 2 | IPR030413 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF14 ZBTB7C MECOM ZNF221 ZNF223 ZNF598 PRDM16 ZNF441 ZNF222 | 8.71e-04 | 775 | 61 | 9 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF14 ZBTB7C MECOM ZNF221 ZNF223 ZNF598 PRDM16 ZNF441 ZNF222 | 8.87e-04 | 777 | 61 | 9 | PS00028 |
| Domain | Znf_C2H2-like | ZNF14 ZBTB7C MECOM ZNF221 ZNF223 ZNF598 PRDM16 ZNF441 ZNF222 | 1.05e-03 | 796 | 61 | 9 | IPR015880 |
| Domain | Znf_C2H2 | ZNF14 ZBTB7C MECOM ZNF221 ZNF223 ZNF598 PRDM16 ZNF441 ZNF222 | 1.14e-03 | 805 | 61 | 9 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF14 ZBTB7C MECOM ZNF221 ZNF223 ZNF598 PRDM16 ZNF441 ZNF222 | 1.17e-03 | 808 | 61 | 9 | SM00355 |
| Domain | - | 1.57e-03 | 679 | 61 | 8 | 3.30.160.60 | |
| Domain | zf-C2H2 | 1.79e-03 | 693 | 61 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.81e-03 | 694 | 61 | 8 | IPR013087 | |
| Domain | TIR | 2.12e-03 | 21 | 61 | 2 | SM00255 | |
| Domain | TIR | 2.32e-03 | 22 | 61 | 2 | PF01582 | |
| Domain | - | 2.54e-03 | 23 | 61 | 2 | 3.40.50.10140 | |
| Domain | zf-DHHC | 2.54e-03 | 23 | 61 | 2 | PF01529 | |
| Domain | TIR | 2.77e-03 | 24 | 61 | 2 | PS50104 | |
| Domain | DHHC | 3.00e-03 | 25 | 61 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 3.00e-03 | 25 | 61 | 2 | IPR001594 | |
| Domain | TIR_dom | 3.00e-03 | 25 | 61 | 2 | IPR000157 | |
| Domain | Galactose-bd-like | 3.60e-03 | 94 | 61 | 3 | IPR008979 | |
| Domain | FYVE | 4.02e-03 | 29 | 61 | 2 | PF01363 | |
| Domain | FYVE | 4.02e-03 | 29 | 61 | 2 | SM00064 | |
| Domain | LRRCT | 4.89e-03 | 32 | 61 | 2 | PF01463 | |
| Domain | Znf_FYVE-rel | 5.50e-03 | 34 | 61 | 2 | IPR017455 | |
| Domain | KRAB | 6.22e-03 | 358 | 61 | 5 | PS50805 | |
| Domain | KRAB | 6.22e-03 | 358 | 61 | 5 | PF01352 | |
| Domain | Znf_FYVE | 6.84e-03 | 38 | 61 | 2 | IPR000306 | |
| Domain | KRAB | 7.05e-03 | 369 | 61 | 5 | SM00349 | |
| Domain | KRAB | 7.13e-03 | 370 | 61 | 5 | IPR001909 | |
| Domain | ZF_FYVE | 7.56e-03 | 40 | 61 | 2 | PS50178 | |
| Domain | SET | 9.90e-03 | 46 | 61 | 2 | SM00317 | |
| Domain | - | 1.07e-02 | 48 | 61 | 2 | 2.120.10.80 | |
| Domain | SET_dom | 1.16e-02 | 50 | 61 | 2 | IPR001214 | |
| Domain | SET | 1.16e-02 | 50 | 61 | 2 | PS50280 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.07e-22 | 45 | 53 | 13 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 HGS USP17L6P USP17L5 USP17L10 TNKS USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.18e-16 | 191 | 53 | 15 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 TNIP2 HGS USP17L6P USP17L5 USP17L10 TNKS USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.03e-15 | 262 | 53 | 16 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 HGS USP17L24 USP17L5 USP17L10 TNKS USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.95e-15 | 221 | 53 | 15 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 TNIP2 HGS USP17L24 USP17L5 USP17L10 TNKS USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.24e-15 | 299 | 53 | 16 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.15e-10 | 318 | 53 | 13 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 KLHL25 USP17L12 USP17L17 USP17L20 USP17L11 TNIP2 HGS USP17L24 LAMB2 USP17L5 USP17L10 TNKS USP17L19 NUP93 USP17L22 USP17L15 USP17L13 USP17L18 | 7.64e-07 | 1475 | 53 | 19 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 KLHL25 USP17L12 USP17L17 USP17L20 USP17L11 TNIP2 HGS USP17L6P USP17L5 USP17L10 TNKS USP17L19 NUP93 USP17L22 USP17L15 USP17L13 USP17L18 | 1.54e-06 | 1389 | 53 | 18 | MM15307 |
| Pathway | WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1 | 6.12e-04 | 10 | 53 | 2 | M45510 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.36e-31 | 21 | 66 | 13 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.36e-31 | 21 | 66 | 13 | 8756639 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.36e-31 | 21 | 66 | 13 | 8622927 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.36e-31 | 21 | 66 | 13 | 14583620 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.36e-31 | 21 | 66 | 13 | 12447969 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.36e-31 | 21 | 66 | 13 | 18980247 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.75e-31 | 22 | 66 | 13 | 9154835 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.42e-30 | 33 | 66 | 14 | 20228807 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 15780755 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 19188362 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 17109758 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 11941478 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 20388806 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 14699124 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 10936051 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.42e-30 | 34 | 66 | 14 | 21448158 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.88e-30 | 24 | 66 | 13 | 8995226 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.02e-30 | 35 | 66 | 14 | 21239494 |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.02e-30 | 35 | 66 | 14 | 16611142 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.99e-30 | 25 | 66 | 13 | 21115691 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 6.58e-30 | 36 | 66 | 14 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.06e-29 | 37 | 66 | 14 | 20228808 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.20e-29 | 26 | 66 | 13 | 35816173 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 7.77e-29 | 29 | 66 | 13 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.95e-25 | 50 | 66 | 13 | 31806660 |
| Pubmed | USP17L21 ZBTB7C USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.82e-11 | 674 | 66 | 14 | 37196079 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L19 USP17L18 | 3.03e-09 | 119 | 66 | 7 | 28625976 |
| Pubmed | High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML. | 3.55e-06 | 2 | 66 | 2 | 25567132 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27586271 | ||
| Pubmed | Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells. | 3.55e-06 | 2 | 66 | 2 | 19887600 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 32810576 | ||
| Pubmed | Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists. | 3.55e-06 | 2 | 66 | 2 | 26255864 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27046485 | ||
| Pubmed | TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. | 3.55e-06 | 2 | 66 | 2 | 16105838 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 34342515 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16368889 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 11050005 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 30906301 | ||
| Pubmed | Extracellular RNA Sensing Mediates Inflammation and Organ Injury in a Murine Model of Polytrauma. | 3.55e-06 | 2 | 66 | 2 | 37133342 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19445181 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16537810 | ||
| Pubmed | Skewed endosomal RNA responses from TLR7 to TLR3 in RNase T2-deficient macrophages. | 3.55e-06 | 2 | 66 | 2 | 34161582 | |
| Pubmed | RNA receptors, TLR3 and TLR7, are potentially associated with SLE clinical features. | 3.55e-06 | 2 | 66 | 2 | 33650302 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 20309865 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 35801751 | ||
| Pubmed | Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3. | 3.55e-06 | 2 | 66 | 2 | 25539593 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27084119 | ||
| Pubmed | Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands. | 3.55e-06 | 2 | 66 | 2 | 23019335 | |
| Pubmed | Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. | 3.55e-06 | 2 | 66 | 2 | 18496560 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16109773 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 35063671 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26581984 | ||
| Pubmed | 7.27e-06 | 20 | 66 | 3 | 12743021 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 28544067 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 25008898 | ||
| Pubmed | Prdm3 and Prdm16 cooperatively maintain hematopoiesis and clonogenic potential. | 1.06e-05 | 3 | 66 | 2 | 32437910 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 15634897 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 26603638 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 19776757 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 25309919 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 32044379 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 29947302 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 23425350 | ||
| Pubmed | Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. | 1.06e-05 | 3 | 66 | 2 | 17981792 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 24445780 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 24692849 | ||
| Pubmed | Toll-like receptor polymorphisms and age-related macular degeneration. | 1.06e-05 | 3 | 66 | 2 | 18385087 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 16111635 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 16582916 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 28300057 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 23761632 | ||
| Pubmed | In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C. | 1.06e-05 | 3 | 66 | 2 | 23489702 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 22565312 | ||
| Pubmed | Cryo-EM structures of Toll-like receptors in complex with UNC93B1. | 1.06e-05 | 3 | 66 | 2 | 33432245 | |
| Pubmed | Toll-like receptors 3, 7, and 9 in Juvenile nasopharyngeal angiofibroma. | 1.06e-05 | 3 | 66 | 2 | 25912131 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 16935934 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 30321082 | ||
| Pubmed | Syk and Hrs Regulate TLR3-Mediated Antiviral Response in Murine Astrocytes. | 1.06e-05 | 3 | 66 | 2 | 31089414 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 25126563 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 18021446 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 31481269 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 15210814 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 27405980 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 10449920 | ||
| Pubmed | Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants. | 1.06e-05 | 3 | 66 | 2 | 27729782 | |
| Pubmed | MAVS mediates a protective immune response in the brain to Rift Valley fever virus. | 1.06e-05 | 3 | 66 | 2 | 35584192 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 17675254 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 29290528 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 19559490 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 29768176 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 37020259 | ||
| Pubmed | A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a. | 1.06e-05 | 3 | 66 | 2 | 18619962 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 34211474 | ||
| Pubmed | 1.63e-05 | 282 | 66 | 6 | 23667531 | ||
| Pubmed | 1.81e-05 | 601 | 66 | 8 | 33658012 | ||
| Pubmed | Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. | 2.12e-05 | 4 | 66 | 2 | 21990957 | |
| Interaction | FLT3 interactions | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 RNF213 USP17L19 NUP93 USP17L18 | 3.95e-07 | 318 | 60 | 9 | int:FLT3 |
| Cytoband | 4p16.1 | USP17L21 USP17L23 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.09e-28 | 79 | 66 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | ZFYVE28 USP17L21 USP17L23 USP17L12 USP17L17 USP17L20 USP17L11 TNIP2 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.73e-25 | 222 | 66 | 17 | chr4p16 |
| Cytoband | 16q13 | 1.24e-03 | 36 | 66 | 2 | 16q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q13 | 1.53e-03 | 40 | 66 | 2 | chr16q13 | |
| Cytoband | 19q13.2 | 1.74e-03 | 164 | 66 | 3 | 19q13.2 | |
| Cytoband | 4p16.3 | 6.73e-03 | 85 | 66 | 2 | 4p16.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF14 ZBTB7C MECOM ZNF221 ZNF223 ZNF598 PRDM16 ZNF441 ZNF222 | 1.07e-05 | 718 | 37 | 9 | 28 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.52e-05 | 34 | 37 | 3 | 487 | |
| GeneFamily | CD molecules|Toll like receptors | 1.81e-04 | 10 | 37 | 2 | 948 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 5.44e-04 | 17 | 37 | 2 | 1197 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 1.09e-03 | 24 | 37 | 2 | 76 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 1.83e-03 | 31 | 37 | 2 | 81 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.27e-20 | 86 | 64 | 13 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.45e-19 | 112 | 64 | 13 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.00e-16 | 160 | 64 | 13 | MM1155 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | ROCK2 USP17L21 USP17L12 SMIM14 USP17L17 USP17L20 USP17L11 USP17L6P SSMEM1 USP17L5 CCL1 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.96e-10 | 1072 | 64 | 17 | MM1031 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.64e-09 | 647 | 64 | 13 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L21 GJB5 USP17L12 USP17L17 USP17L20 USP17L11 USP17L6P USP17L5 USP17L10 TMEM183BP USP17L19 NUP93 USP17L22 USP17L15 USP17L13 USP17L18 | 2.02e-08 | 1198 | 64 | 16 | MM1062 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | CEP104 USP17L21 KLHL25 USP17L12 USP17L17 USP17L20 USP17L11 TLR3 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.78e-08 | 1226 | 64 | 16 | MM979 |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN | 9.50e-06 | 200 | 64 | 6 | M4269 | |
| Coexpression | GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_3DY_UP | 5.84e-05 | 5 | 64 | 2 | M41182 | |
| Coexpression | GIAROLA_SILVA_BLOOD_INFLUENZA_A_AGE_21_51YO_3DY_UP | 5.84e-05 | 5 | 64 | 2 | M41181 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 1.13e-04 | 194 | 64 | 5 | M7306 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP | 1.24e-04 | 198 | 64 | 5 | M6361 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN | 1.24e-04 | 198 | 64 | 5 | M4272 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 1.30e-04 | 200 | 64 | 5 | M9391 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN | 1.30e-04 | 200 | 64 | 5 | M6585 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.52e-27 | 46 | 64 | 14 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.56e-24 | 69 | 64 | 14 | DOID:1682 (implicated_via_orthology) |
| Disease | smoking status measurement, systolic blood pressure | 3.73e-04 | 156 | 64 | 4 | EFO_0006335, EFO_0006527 | |
| Disease | sex interaction measurement, ulcerative colitis | 6.17e-04 | 17 | 64 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 6.17e-04 | 17 | 64 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | migraine disorder, Headache | 8.76e-04 | 86 | 64 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 9.36e-04 | 88 | 64 | 3 | EFO_0000341, EFO_0006527 | |
| Disease | anogenital venereal wart (is_marker_for) | 1.46e-03 | 26 | 64 | 2 | DOID:11168 (is_marker_for) | |
| Disease | cytotoxicity measurement, response to clozapine | 1.81e-03 | 29 | 64 | 2 | EFO_0006952, GO_0097338 | |
| Disease | nicotine dependence symptom count | 3.44e-03 | 285 | 64 | 4 | EFO_0009262 | |
| Disease | systolic blood pressure, alcohol consumption measurement | 4.70e-03 | 47 | 64 | 2 | EFO_0006335, EFO_0007878 | |
| Disease | smoking status measurement, diastolic blood pressure | 5.03e-03 | 159 | 64 | 3 | EFO_0006336, EFO_0006527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQRHRKMLRHCPSKR | 81 | P22362 | |
| RMCLRHSRECLALKQ | 511 | A6NF34 | |
| VHRLKKDIRRCHRMS | 116 | O95503 | |
| REHRMFDQQICHRSK | 1656 | Q12802 | |
| CETHRARMVKHHCCP | 481 | Q96KQ7 | |
| RMERLRCHAVHVALV | 481 | Q8N1F7 | |
| KHNCLQRRCMPLHSR | 36 | P0DMC3 | |
| TVIRRKHHCRSCGKI | 831 | Q9HCC9 | |
| LCRHKRMHADCRTQI | 391 | Q03112 | |
| HNEMEKNRRAHLRLC | 61 | Q05195 | |
| CNIKHRGHVRESEMC | 636 | Q2TV78 | |
| DTRHRHLVLQMALKC | 346 | Q13946 | |
| CHCRQHMVGRRCEQV | 541 | P55268 | |
| SRRMRLTHCGLQEKH | 976 | Q86WI3 | |
| AMVILCRFRKLHCTR | 171 | P41586 | |
| CRFRKLHCTRNFIHM | 176 | P41586 | |
| NKCHKARRCHMNRTL | 176 | Q99575 | |
| HCLMLTRCDHCKQVV | 776 | O60308 | |
| CVLAHLNTLRKHCMF | 31 | Q9H0H3 | |
| LKRHHARMQLLRKCS | 61 | Q9BVV2 | |
| LHHSMCTRKRHRRCE | 491 | Q99698 | |
| KRCHECLAARKAQAM | 211 | O95377 | |
| SLNRRMQKARHCGHC | 106 | O43908 | |
| LKIEHTCRLHRRMLN | 151 | Q96KS9 | |
| HRCKSRVERHDMNTL | 21 | Q9ULS5 | |
| RSCHKMCIDIQRRQI | 326 | Q9UL63 | |
| RIGHCMLFHSKNRCL | 456 | Q9UL63 | |
| NCMEHALIACHPRTR | 266 | O75452 | |
| YQMSERHCLHCKALR | 191 | Q8WWF3 | |
| LHCLRACVIRSLYHM | 196 | Q1AE95 | |
| FSNLCRHKRMHADCR | 406 | Q9HAZ2 | |
| RHKRMHADCRTQIKC | 411 | Q9HAZ2 | |
| CVCSHEHAMRRLINL | 11 | Q96QK8 | |
| NHCRFITRDLMRDHK | 491 | O15091 | |
| NCGSIERHQKRHLMR | 146 | Q32M92 | |
| TAHMCQHLAKCLDER | 161 | Q8NFZ5 | |
| HREAIEKHARFRQMC | 4051 | Q63HN8 | |
| RRNLRCHMVERACEI | 61 | Q8N8Z8 | |
| NHALCLRRGMFKSHC | 861 | O15455 | |
| FRCRSALTVHCKLHM | 241 | Q9UK11 | |
| HHCSVCKRCIRKMDH | 141 | Q9NYG2 | |
| THKDRSCYICHRQML | 1236 | O95271 | |
| REHSQTCHRHKGCML | 111 | D6R9N7 | |
| CHRCRVQFGVMTRKH | 166 | O14964 | |
| REHSQTCHRHKGCML | 111 | A8MUK1 | |
| REHSQTCHRHKGCML | 111 | D6R901 | |
| REHSQTCHRHKGCML | 111 | C9JLJ4 | |
| LECRRCHIKCHKDHM | 1291 | O75116 | |
| REHSQTCHRHKGCML | 111 | D6RCP7 | |
| CVMCRESREHRPHTA | 121 | Q12899 | |
| KMLLLHHNRFLCTCD | 776 | Q9NYK1 | |
| CISHRRLTHRMKEAG | 111 | Q9BQ16 | |
| LCNKCNLMRPKRSHH | 91 | Q8IVQ6 | |
| QHMRRQHELFCCRLC | 136 | Q86UK7 | |
| REHSQTCHRHKGCML | 111 | C9JPN9 | |
| DHLHRHIKRQSCRMA | 461 | A1YPR0 | |
| ICRRDFCKHQMVHTG | 376 | Q9UK13 | |
| REHSQTCHRHKGCML | 111 | Q0WX57 | |
| REHSQTCHRHKGCML | 111 | Q6QN14 | |
| REHSQTCHRHKGCML | 111 | D6RA61 | |
| REHSQTCHRHKGCML | 111 | C9J2P7 | |
| REHSQTCHRHKGCML | 111 | D6RBQ6 | |
| REHSQTCHRHKGCML | 111 | D6RBM5 | |
| REHSQTCHRHKGCML | 111 | D6RJB6 | |
| RCRSALKVHCKLHMR | 211 | Q9UK12 | |
| REHSQTCHRHKGCML | 111 | C9JJH3 | |
| ACDQLHFCRRHMLGK | 101 | Q96H79 | |
| HRNQGKNRRCHMVER | 56 | P17017 | |
| REHSQTCHRHKGCML | 111 | C9JVI0 |